Baldassarro Vito Antonio, Stanzani Agnese, Giardino Luciana, Calzà Laura, Lorenzini Luca
Department of Veterinary Medical Science, University of Bologna, Bologna, Italy.
Interdepartmental Center for Industrial Research in Life Sciences and Technologies, University of Bologna, Bologna, Italy.
Neural Regen Res. 2022 Nov;17(11):2376-2380. doi: 10.4103/1673-5374.335834.
Efficient strategies for neuroprotection and repair are still an unmet medical need for neurodegenerative diseases and lesions of the central nervous system. Over the last few decades, a great deal of attention has been focused on white matter as a potential therapeutic target, mainly due to the discovery of the oligodendrocyte precursor cells in the adult central nervous system, a cell type able to fully repair myelin damage, and to the development of advanced imaging techniques to visualize and measure white matter lesions. The combination of these two events has greatly increased the body of research into white matter alterations in central nervous system lesions and neurodegenerative diseases and has identified the oligodendrocyte precursor cell as a putative target for white matter lesion repair, thus indirectly contributing to neuroprotection. This review aims to discuss the potential of white matter as a therapeutic target for neuroprotection in lesions and diseases of the central nervous system. Pivot conditions are discussed, specifically multiple sclerosis as a white matter disease; spinal cord injury, the acute lesion of a central nervous system component where white matter prevails over the gray matter, and Alzheimer's disease, where the white matter was considered an ancillary component until recently. We first describe oligodendrocyte precursor cell biology and developmental myelination, and its regulation by thyroid hormones, then briefly describe white matter imaging techniques, which are providing information on white matter involvement in central nervous system lesions and degenerative diseases. Finally, we discuss pathological mechanisms which interfere with myelin repair in adulthood.
对于神经退行性疾病和中枢神经系统损伤而言,有效的神经保护和修复策略仍是尚未满足的医学需求。在过去几十年里,白质作为一个潜在的治疗靶点受到了大量关注,这主要是由于在成体中枢神经系统中发现了少突胶质前体细胞,这种细胞类型能够完全修复髓鞘损伤,还由于先进成像技术的发展,可用于可视化和测量白质损伤。这两个事件的结合极大地增加了对中枢神经系统损伤和神经退行性疾病中白质改变的研究,并将少突胶质前体细胞确定为白质损伤修复的假定靶点,从而间接地有助于神经保护。本综述旨在讨论白质作为中枢神经系统损伤和疾病中神经保护治疗靶点的潜力。文中讨论了关键病症,特别是作为白质疾病的多发性硬化症;脊髓损伤,这是一种中枢神经系统组成部分的急性损伤,其中白质比灰质更占优势;以及阿尔茨海默病,直到最近白质在该病中都被视为辅助成分。我们首先描述少突胶质前体细胞生物学和发育性髓鞘形成,以及甲状腺激素对其的调节,然后简要描述白质成像技术,这些技术正在提供有关白质在中枢神经系统损伤和退行性疾病中受累情况的信息。最后,我们讨论在成年期干扰髓鞘修复的病理机制。